Search clinical trials for: GLU-02

Total 1430 results

Afexa Life Sciences Inc

Terminated

GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States
University of Iowa

Completed

Hyperglycemia, Exercise, and Endothelial Function

Hyperglycemia | Endothelial Function

United States
Zhongmou Therapeutics

Not yet recruiting

Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients (ZM-02)

Retinitis Pigmentosa

China
Chung Shan Medical University

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.

Sjögren's Syndrome

Taiwan
MediWound Ltd

Recruiting

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Nodular Basal Cell Carcinoma | Superficial Basal Cell Carcinoma

United States
University Hospital Inselspital, Berne
University of Lausanne; University of Bern

Completed

Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes (CARBEX1)

Hypoglycemia | Exercise | Type 1 Diabetes Mellitus | Carbohydrate Metabolism

Switzerland
ADIR Association

Suspended

Oxygen Titration Protocol for Exertion of COPD Patients by an Automated Adjustment Device

COPD | Chronic Respiratory Insufficiency

France
Translational Research Center for Medical Innovation...

Terminated

Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M

Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) | Neutral Lipid Storage Disease With Myopathy (NLSD-M)

Italy, Japan
Dr. Reddy's Laboratories Limited

Completed

DFN-02 Open Label Safety Study in Patients With Acute Migraine

Acute Migraine

United States
Tceleron Therapeutics, Inc.

Terminated

A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

United States
Amniotics AB

Completed

A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI

COVID-19

Sweden
Attralus, Inc.
Novotech (Australia) Pty Limited

Recruiting

Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis (AT02-001)

Amyloidosis; Systemic

United States, Australia
Parion Sciences

Completed

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Cystic Fibrosis

United States
PRCL Research Inc.

Completed

A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis | Psoriasis Vulgaris

Canada, Slovakia, Ukraine
Eloxx Pharmaceuticals, Inc.

Terminated

Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers

Genetic Diseases | Nonsense Mutations
AVROBIO

Terminated

Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease

Gaucher Disease

United States, Canada
Eloxx Pharmaceuticals, Inc.
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ELX-02 in Healthy Adults

Genetic Disease | Nonsense Mutation

Belgium
Neurophth Therapeutics Inc

Recruiting

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

Leber Hereditary Optic Neuropathy (LHON)

China, United States
Lipid Therapeutics GmbH

Unknown

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

Abdominal Pain | Diarrhea | Ulcerative Colitis | Large Intestine

Germany, Lithuania, Romania
Vedic Lifesciences Pvt. Ltd.

Recruiting

A Study to Evaluate the Efficacy of VL-NL-02 on Sleep Quality.

Mood and Sleep Quality

India
Henan Cancer Hospital
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies

Hematologic Malignancies

China
MEI HENG
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
CHABiotech CO., Ltd

Active, not recruiting

Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of
Fresh Tracks Therapeutics, Inc.
Syneos Health; Innovaderm Research Inc.

Terminated

A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis Eczema

Canada
Mylan Specialty, LP

Completed

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

Pain | Acute Pain | Post Operative Pain

United States
Biomedical Solutions Inc.

Withdrawn

Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke (T-02)

Thrombosis | Acute Ischemic Stroke | Large Vessel Occlusion | Vascular Occlusion | Endovascular
MediWound Ltd

Completed

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Diabetic Foot Ulcer | Venous Leg Ulcer

United States
Hospital Clinic of Barcelona

Unknown

Individualized Perioperative Open Lung Ventilatory Approach in Emergency Abdominal Laparotomy. A Prospective Multicenter Randomized Controlled Trial.

Ventilator Lung
Oculis
ORA, Inc.

Active, not recruiting

Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease (RELIEF)

Dry Eye Disease

United States
Kai Lin Xu，MD
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Neoplasms | Hematologic Diseases | Hematologic Neoplasms

China
Nippon Shinyaku Co., Ltd.

Active, not recruiting

Extension Study of NS-089/NCNP-02 in DMD

Duchenne Muscular Dystrophy (DMD)

Japan
HealOr

Unknown

Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis (ARD)

Breast Cancer

Israel
Seed Health

Completed

Randomized, Double-blind, Placebo-controlled Trial Investigating the Role of a Personal Care Product on Vaginal Health

Vaginal Personal Care

United States
Xiaoyu Zhu
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Neoplasms | Hematologic Diseases | Hematologic Neoplasms

China
He Huang
Nanjing Bioheng Biotech Co., Ltd.

Recruiting

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Neoplasms | Neoplasms by Site | Hematologic Diseases | Hematologic Neoplasms

China
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-089/NCNP-02 in DMD

Duchenne Muscular Dystrophy

Japan
Galectin Therapeutics Inc.

Completed

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Psoriasis

United States
Shanghai EpimAb Biotherapeutics Co., Ltd.

Recruiting

A Study of EMB-02 in Participants With Advanced Solid Tumors

Advanced Solid Tumors

Australia, China, United States
University of Pennsylvania
Prostate Cancer Foundation

Recruiting

TmPSMA-02 in mCRPC

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

United States
PRCL Research Inc.

Completed

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

Psoriasis

Canada
Oyster Point Pharma, Inc.

Completed

Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study)

Dry Eye Disease

United States
ViaCyte
California Institute for Regenerative Medicine (CIRM); Horizon 2020 - European...

Completed

A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness

Type 1 Diabetes Mellitus With Hypoglycemia

United States, Canada, Belgium
Vedic Lifesciences Pvt. Ltd.

Completed

Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain

Joint Pain

India
Gedeon Richter Plc.

Completed

Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta

Bioequivalence

United Kingdom
Dr. Reddy's Laboratories Limited
Duke Clinical Research Institute

Completed

Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery

Surgical Site Infections

United States
Nobelpharma

Completed

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Wilson's Disease
Nobelpharma

Completed

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

Zinc Deficiency

Japan
Ache Laboratorios Farmaceuticos S.A.

Withdrawn

Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Vitiligo

Brazil
Galectin Therapeutics Inc.

Completed

Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Non-Alcoholic Steatohepatitis (NASH)

United States
Galectin Therapeutics Inc.

Active, not recruiting

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE)

Cirrhosis | NASH - Nonalcoholic Steatohepatitis | Prevention of Esophageal Varices

United States, France, Spain, Australia, Canada, Israel, Puerto Rico, Belgium, Argentina, Chile, Germany, Korea, Republic of, Mexico, Poland, United Kingdom

Search clinical trials for: GLU-02

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations